GENN OTC
Genesis Healthcare, Inc.
1W: +0.0%
1M: +0.0%
3M: -50.0%
1Y: -90.9%
3Y: -99.9%
5Y: -100.0%
$0.00
Last traded 2025-08-18 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$3.9B
-14.4% ▼
5Y CAGR: -7.0%
Gross Profit
$1.7B
-20.7% ▼
5Y CAGR: -6.7%
Operating Income
$1.1B
-29.0% ▼
5Y CAGR: +28.1%
Net Income
-$59M
-503.3% ▼
EPS (Diluted)
$-0.53
-630.0% ▼
EBITDA
$136M
-43.5% ▼
5Y CAGR: -19.1%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $5.7B | $5.4B | $5.0B | $4.6B | $3.9B |
| YoY Growth | +2.0% | -6.3% | -7.4% | -8.3% | -14.4% |
| Cost of Revenue | $3.4B | $3.0B | $2.8B | $2.5B | $2.3B |
| Gross Profit | $2.4B | $2.3B | $2.2B | $2.1B | $1.7B |
| Gross Margin | 41.2% | 43.5% | 44.0% | 45.6% | 42.2% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $332M | $318M | $279M | $532M | $541M |
| Operating Expenses | $2.1B | $170M | $2.0B | $594M | $595M |
| Operating Income | $254M | $183M | $210M | $1.5B | $1.1B |
| Operating Margin | 4.4% | 3.4% | 4.2% | 32.6% | 27.0% |
| Interest Expense | $529M | $499M | $464M | $180M | $135M |
| Income Before Tax | -$136M | -$970M | -$375M | $9M | -$107M |
| Tax Expense | -$17M | -$10M | -$2M | $2M | -$4M |
| Net Income | -$64M | -$579M | -$235M | $15M | -$59M |
| Net Margin | -1.1% | -10.8% | -4.7% | 0.3% | -1.5% |
| EPS (Diluted) | $-0.41 | $-6.15 | $-2.33 | $0.10 | $-0.53 |
| EBITDA | $647M | -$214M | $310M | $313M | $136M |
| Shares Outstanding | 91M | 94M | 101M | 165M | 112M |